Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blann

Showing results (351-360 of 420) with videos related to

Pageof 42
Sort By:
Journal of Human Hypertension|June 26, 2002
Oxidative stress in malignant and non-malignant phase hypertensionG Y H Lip, E Edmunds, S L Nuttall, et al.
Angiology|May 24, 2011
Angiogenin and hemoxygenase in pregnancy: influence of hypertensionVelore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Angiology|May 11, 2011
Soluble Fas and Fas ligand in pregnancy: influence of hypertensionVelore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 12, 2011
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factorV J Karthikeyan, Andrew D Blann, Sabah Baghdadi, et al.
American Journal of Hypertension|September 15, 2004
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)Muzahir H Tayebjee, Sunil Nadar, Andrew D Blann, et al.
Journal of Internal Medicine|March 30, 2007
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes TrialG I Varughese, J V Patel, J Tomson, et al.
Molecular Diversity|October 13, 2006
Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cellsLei Guo, Lu Zhang, Yongming Sun, et al.
Pediatric Cardiology|March 31, 2015
The Number of GT(n) Repeats in the Hemeoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory MarkersSherif Sayed, Naglaa K Idriss, Andrew Blann, et al.
European Journal of Preventive Cardiology|April 28, 2012
Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UKHeather Kendall, Alexandra Marley, Jeetesh V Patel, et al.
Geriatric Nursing (New York, N.Y.)|November 22, 2020
The effect of PARO robotic seals for hospitalized patients with dementia: A feasibility studyPatricia A Kelly, L Annette Cox, Sandra F Petersen, et al.
Pageof 42

Showing results (351-360 of 420) with videos related to

Sort By:
Pageof 42
Journal of Human Hypertension|June 26, 2002
Oxidative stress in malignant and non-malignant phase hypertensionG Y H Lip, E Edmunds, S L Nuttall, et al.
Angiology|May 24, 2011
Angiogenin and hemoxygenase in pregnancy: influence of hypertensionVelore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Angiology|May 11, 2011
Soluble Fas and Fas ligand in pregnancy: influence of hypertensionVelore J Karthikeyan, Gregory Y H Lip, Sabah Baghdadi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 12, 2011
Endothelial dysfunction in hypertension in pregnancy: associations between circulating endothelial cells, circulating progenitor cells and plasma von Willebrand factorV J Karthikeyan, Andrew D Blann, Sabah Baghdadi, et al.
American Journal of Hypertension|September 15, 2004
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)Muzahir H Tayebjee, Sunil Nadar, Andrew D Blann, et al.
Journal of Internal Medicine|March 30, 2007
Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes TrialG I Varughese, J V Patel, J Tomson, et al.
Molecular Diversity|October 13, 2006
Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cellsLei Guo, Lu Zhang, Yongming Sun, et al.
Pediatric Cardiology|March 31, 2015
The Number of GT(n) Repeats in the Hemeoxygenase-1 Gene Promoter is Increased in Pediatric Heart Failure but is Unrelated to Renal, Antioxidant and Anti-inflammatory MarkersSherif Sayed, Naglaa K Idriss, Andrew Blann, et al.
European Journal of Preventive Cardiology|April 28, 2012
Hospital delay in South Asian patients with acute ST-elevation myocardial infarction in the UKHeather Kendall, Alexandra Marley, Jeetesh V Patel, et al.
Geriatric Nursing (New York, N.Y.)|November 22, 2020
The effect of PARO robotic seals for hospitalized patients with dementia: A feasibility studyPatricia A Kelly, L Annette Cox, Sandra F Petersen, et al.
Pageof 42